Search the Newsreel

ASX 200: Why Is Insurance Australia Group Dividend Strength in Focus?

Is Insurance Australia Group’s (ASX:IAG) Higher Dividend With Softer Earnings Reframing Its Capital Allocation Story?

Walleye Capital LLC Takes $12.97 Million Position in Iamgold Corporation $IAG

Walleye Capital LLC has acquired a new position in Iamgold Corporation, purchasing 818,721 shares valued at approximately $12.97 million, representing 0.14% of the company. Other institutional investors have also adjusted their holdings in Iamgold, with institutional ownership collectively reaching 47.08%. Analysts maintain a "Moderate …

Krsnaa Diagnostics Q1FY27 net profit falls 19% to ₹166 crore

Rob Franch resigns as CIO at Carriage Services

Rob Franch has resigned from his position as Chief Information Officer at Carriage Services (CSV), effective August 13, 2026. The company has initiated a search for his replacement. His resignation was not due to any disagreements with the company or its board.

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG

This article announces that QIAGEN N.V. has received a notification from the AFM (the Netherlands Authority For the Financial Markets) regarding a voting rights announcement. Wellington Management Group LLP reported a transaction on August 12, 2026, indicating they hold 4.96% of the voting rights …

Dasa (DASA3) desaba 17% após resultados; XP e BTG fazem suas apostas

Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …

T. Rowe Price Associates (DGX) discloses 5.43M Quest Diagnostics shares in 13G/A

T. Rowe Price Associates, Inc. filed an amended Schedule 13G, reporting a beneficial ownership of 5,428,244 shares, or 4.9% of Quest Diagnostics Inc. common stock. The firm holds sole voting power over 5,321,387 shares and sole dispositive power over all 5,428,244 shares, while explicitly …

Armistice Capital discloses 9.99% Co-Diagnostics (CODX) holding via Master Fund

Armistice Capital, LLC and its managing member Steven Boyd have reported a beneficial ownership of 9.99% in Co-Diagnostics (CODX), amounting to 559,706 shares. These shares are held by Armistice Capital Master Fund Ltd., with Armistice Capital serving as the investment manager. The filing indicates …

Co-diagnostics(CODX) Stock Options Chain | Quotes & News

This article appears to be a stub or a placeholder, as the content provided is only "Document". It is intended to cover the stock options chain, quotes, and news for Co-diagnostics (CODX).

Diageo plc (NYSE:DEO) Announces $1.20 Dividend

Diageo plc (NYSE:DEO) has announced a dividend of $1.20 per share, payable on December 3rd to shareholders of record as of October 16th. This dividend represents a 252.0% yield and is well-covered by the company's earnings with a payout ratio of 22.5%. Analysts have …

Oppenheimer Initiates Carriage Services at Outperform With $48 Price Target

Oppenheimer has initiated coverage of Carriage Services (NYSE:CSV) with an Outperform rating and a price target of $48. This news follows a previous adjustment by Barrington, which lowered its price target to $50 from $60 while maintaining an Outperform rating. Carriage Services recently reported …

Krsnaa Q1 FY27 slides: 22% revenue growth, retail surges 64% By Investing.com

4% Undervalued? Qiagen (QGEN) As Q2 Beat And FDA Clearance Lift The Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Qiagen (QGEN) has drawn fresh attention after surpassing its own sales and EPS outlook for Q2 2026 and reaffirming full year guidance, along with FDA …

KRSNAA: Q1 FY27 revenue up 22% YoY; retail surged 64%, margins to improve as new projects mature

Transcript : Krsnaa Diagnostics Limited, Q1 2027 Earnings Call, Aug 14, 2026

Krsnaa Q1 FY27 slides: 22% revenue growth, retail surges 64%

Pharmaniaga 2Q Net Profit Surges 200%, Secures RM281.7M Insulin Contract

Earnings call transcript: Krsnaa Diagnostics posts 22% revenue growth in Q1 2026

Diageo plc (LON:DGE) Given Consensus Rating of "Moderate Buy" by Analysts

Diageo plc (LON:DGE) has received a consensus "Moderate Buy" rating from analysts, with four out of seven recommending a buy and three suggesting a hold. The average 12-month price target is GBX 2,029. Insider transactions show executives purchased 4,541 shares worth approximately $6.99 million …

CODX|Co-Diagnostics Inc|Price:1.460|Chg%:-0.020

Co-Diagnostics Inc (CODX) stock closed at $1.39, down 6.71% on August 14th, with a market cap of $8.75 million. The company recently reported Q2 2026 revenue of $166,000, narrowed losses, and filed its flu and RSV assay with the FDA. Analysts currently rate CODX …

Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX

Assenagon Asset Management S.A. increased its stake in Quest Diagnostics Incorporated by 39.1% in the second quarter, acquiring 4,334 shares and bringing its total holdings to 15,405 shares valued at approximately $3.27 million. The medical research company reported strong Q2 earnings, exceeding estimates with …

CLEO Diagnostics slips again as ovarian cancer test enters validation phase ahead of 2027 FDA filing

Lumos Diagnostics Holdings (ASX:LDX)Turns FDA Clearance Into Sales as FebriDx Revenue Multiplies in the US

EKF Diagnostics tightens share base with latest buyback on AIM

Krsnaa Diagnostics consolidated net profit declines 19.35% in the June 2026 quarter

KRSNAA: Q1 FY27 revenue up 22% YoY, retail surges 64%, but margins compress on higher fixed costs

Lucid Diagnostics Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LUCD) 2026-08-13

Lucid Diagnostics Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Access Progress Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

Suraksha Diagnostic Ltd (NSE:SURAKSHA) (Q1 2027) Earnings Call Highlights: Strong 21% Revenue ...

Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Quest Diagnostics Inc (DGX), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that DGX has a momentum score of 3.90, trading between resistance at $249.41 and support at $213.38. The …

Lucid Diagnostics (LUCD) Stock Slips As Lofty P S Meets Heavy Losses

IAMGOLD (IAG) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President, Business Development and Investor Relations - Graeme Jennings President and Chief Executive Officer - Renaud Adams Chief Financial Officer - Marthinus Theunissen Chief Operating Officer - Bruno …